Actoplus Met [Actos and Metformin]
Actoplus Met is a combo of Actos and Metformin

According to Takeda Pharmaceutical Co. news release, U.S. FDA has
approved its new drug - Actoplus Met for diabetes treatment and they plan
to sell it in Octobor.

Actoplus Met is a single tablet of two existing diabete drugs: Actos and
metformin. Actos (pioglitazone HCl) is a diabetes drug used to improve
insulin resistance and metformin is also a diabetes drug used to control the
glucose level produced by the liver.

Actoplus Met will have two strength-combinations: 15 mg/500 mg and 15
mg / 850 mg. Both are to be given once daily or in divided doses not
exceeding the maximum recommended daily doses of pioglitazone 45 mg
and metformin 2,550 mg.

The new drug product may mean that type 2 diabetes patients take one
combo  tablet instead of two tablets for the treatment. However, there is
also a chance that the individual may need to take divided doses.

References
FDA approves new diabetes pill, Takeda's combination medication
approved by FDA is the company's second approval this summer.
CNN/Money Online Publcation, August 29, 2005.
Nikkei recovers on Wall St gains, Toyota bought
Reuter India, India, Online Publication, August 29 2005.
THIS WEBSITE TALKS ABOUT THE SIDE EFFECTS AND THE POTENTIAL HEALTH BENEFITS OF HERBS, SUPPLEMENTS,
PHYTONUTRIENTS AND DRUG PRODUCTS. THIS WEBSITE ALSO TALKS ABOUT SOME POPULAR HEALTH ISSUES AND DISEASES.
ARTICLES IN THIS WEB SITE IS FOR YOUR REFERENCE ONLY. IF YOU HAVE ANY QUESTION, YOU SHOULD CONSULT WITH YOUR
DOCTOR IMMEDIATELY. ALL RIGHTS RESERVED 2008. DO NOT COPY NOR TRANSFER ARTICLES TO OTHER WEBSITES NOR OTHER
FORMS OF PUBLICATIONS.
Privacy Policy. ARTICLE INDEX